CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5. (Q41151327)

27 September 2017

CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5. (English)

1 reference

27 September 2017

1 reference

1

1 reference

27 September 2017

Dragic T

2

1 reference

27 September 2017

Arthos J

3

1 reference

27 September 2017

Binley JM

4

1 reference

27 September 2017

Olson WC

5

1 reference

27 September 2017

Allaway GP

6

1 reference

27 September 2017

Cheng-Mayer C

7

1 reference

27 September 2017

Robinson J

8

1 reference

27 September 2017

Maddon PJ

9

1 reference

27 September 2017

Moore JP

10

1 reference

27 September 2017

language of work or name

English

0 references

publication date

1 November 1996

1 reference

27 September 2017

1 reference

27 September 2017

384

1 reference

27 September 2017

184-187

1 reference

27 September 2017

6605

1 reference

https://scigraph.springernature.com/pub.10.1038/384184a0

27 September 2017

0 references

cites work

HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5

1 reference

7 January 2021

Identification of a major co-receptor for primary isolates of HIV-1

1 reference

7 January 2021

The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates

1 reference

7 January 2021

A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors

1 reference

7 January 2021

CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1

1 reference

7 January 2021

The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain

1 reference

7 January 2021

Delineation of a region of the human immunodeficiency virus type 1 gp120 glycoprotein critical for interaction with the CD4 receptor

1 reference

7 January 2021

Selectivity and antagonism of chemokine receptors

1 reference

7 January 2021

Molecular cloning and functional expression of a new human CC-chemokine receptor gene

1 reference

7 January 2021

Molecular cloning and functional characterization of a novel human CC chemokine receptor (CCR5) for RANTES, MIP-1beta, and MIP-1alpha

1 reference

7 January 2021

Molecular cloning, functional expression, and signaling characteristics of a C-C chemokine receptor

1 reference

7 January 2021

Interleukin-2 regulates CC chemokine receptor expression and chemotactic responsiveness in T lymphocytes.

1 reference

7 January 2021

Relative resistance to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high-risk sexual exposure

1 reference

7 January 2021

Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection

1 reference

7 January 2021

Novel anti-CD4 monoclonal antibodies separate human immunodeficiency virus infection and fusion of CD4+ cells from virus binding

1 reference

7 January 2021

Expression and characterization of CD4-IgG2, a novel heterotetramer that neutralizes primary HIV type 1 isolates

1 reference

7 January 2021

Probing the structure of the human immunodeficiency virus surface glycoprotein gp120 with a panel of monoclonal antibodies

1 reference

7 January 2021

Involvement of the V1/V2 variable loop structure in the exposure of human immunodeficiency virus type 1 gp120 epitopes induced by receptor binding

1 reference

7 January 2021

Replicative function and neutralization sensitivity of envelope glycoproteins from primary and T-cell line-passaged human immunodeficiency virus type 1 isolates.

1 reference

7 January 2021

Enhancement of SIV infection with soluble receptor molecules

1 reference

7 January 2021

Human anti-V2 monoclonal antibody that neutralizes primary but not laboratory isolates of human immunodeficiency virus type 1

1 reference

7 January 2021

Broadly neutralizing monoclonal antibodies to the V3 region of HIV-1 can be elicited by peptide immunization

1 reference

7 January 2021

Simian immunodeficiency virus DNA vaccine trial in macaques.

1 reference

7 January 2021

Identifiers

DOI

10.1038/384184A0

1 reference

Dimensions Publication ID

27 September 2017

0 references

0 references

1 reference